" /> Varlitinib - CISMeF





Preferred Label : Varlitinib;

NCIt definition : An orally bioavailable inhibitor of the epidermal growth factor receptor family with potential antineoplastic activity. Varlitinib selectively and reversibly binds to both EGFR (ErbB-1) and Her-2/neu (ErbB-2) and prevents their phosphorylation and activation, which may result in inhibition of the associated signal transduction pathways, inhibition of cellular proliferation and cell death. EGFR and Her-2 play important roles in cell proliferation and differentiation and are upregulated in various human tumor cell types. Due to the dual inhibition of both EGFR and Her-2, this agent may be therapeutically more effective than agents that inhibit EGFR or Her-2 alone.;

UNII : 846Y8197W1;

InChIKey : UWXSAYUXVSFDBQ-CYBMUJFWSA-N;

CAS number : 845272-21-1; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 845272-21-1 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Molecule name : ARRY-334543;

Chemical formula : C22H19ClN6O2S;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
12/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.